SyntheticMR AB — Investor Relations & Filings

SyntheticMR AB develops and markets software solutions for Magnetic Resonance Imaging (MRI). The company's core product, SyMRI®, is designed to enhance imaging workflow efficiency and provide objective data for clinical decision support. From a single, rapid acquisition sequence, SyMRI generates multiple synthetic contrast-weighted images with adjustable parameters. In addition to these images, the software provides quantitative data, including tissue volumes, parametric maps, and myelin measurements. This quantitative approach supports improved diagnosis, monitoring of disease progression, and evaluation of treatment efficacy. The SyMRI product suite includes applications for neuroimaging (SyMRI NEURO) as well as for knee and spine anatomies.